DENISE AQUINO: Open Payments
NPI 1750988671 · TUSTIN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,050 in 41 payments from 15 companies in 2025. Trend: 2023 $1,572 · 2024 $1,705 · 2025 $2,050
Food & beverage: $2,037Travel & lodging: $13
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 5 | $388 |
| UCB, Inc. | 3 | $373 |
| Gilead Sciences, Inc. | 3 | $279 |
| ViiV Healthcare Company | 8 | $196 |
| GENZYME CORPORATION | 3 | $162 |
| Incyte Corporation | 2 | $144 |
| Lilly USA, LLC | 6 | $135 |
| Xeris Pharmaceuticals, Inc. | 1 | $125 |
| Corcept Therapeutics | 4 | $96 |
| Dexcom, Inc. | 1 | $52 |
Products named: Zoryve, Bimzelx, DOVATO, DUPIXENT, Opzelura, GVOKE HYPOPEN, Livdelzi, Korlym.
Industry payments across CA — which companies pay providers there.
